Skip to main content
. 2021 Jun;10(6):2452–2474. doi: 10.21037/tlcr-21-96

Table 1. Significant factors in univariate cox regression of OS and RFS.

Factors OS RFS
No HR 95% CI P value No HR 95% CI P value
Distance between positive TILs (one positive TIL to another TIL)
   PD-1
    Near (≤125.34 px) 27 1.000
    Far (>125.34 px) 74 1.975 1.078–3.618 0.028
   OX40L
    Near (≤48.14 px for OS, ≤61.55 px for RFS) 92 1.000 98 1.000
    Far (>48.14 px for OS, >61.55 px for RFS) 23 1.788 1.076–2.989 0.025 17 1.801 1.032–3.144 0.038
   OX40
    Near (≤98.33 px) 92 1.000
    Far (>98.33 px) 26 1.752 1.078–2.846 0.024
   KIR-3D
    Near (≤13.44 px) 13 1.000
    Far (>13.44 px) 96 0.416 0.217–0.799 0.008
Distance between positive TCs (one positive TC to another positive TC)
   TIM-3
    Near (≤546.86 px) 59 1.000
    Far (>546.86 px) 11 2.039 1.032–4.030 0.040
   galectin9
    Near (≤85.97 px for OS, ≤119.40 px for RFS) 65 1.000 75 1.000
    Far (>85.97 px for OS, >119.40 px for RFS) 35 1.820 1.105–2.999 0.019 25 1.719 1.002–2.949 0.049
   KIR-2D
    Near (≤24.22 px) 68 1.000
    Far (>24.22 px) 39 1.849 1.151–2.969 0.011
Distance between positive TCs and positive TIL (one positive TC to one positive TIL)
   OX40L
    Near (≤94.06 px) 50 1.000 50 1.000
    Far (>94.06 px) 62 0.570 0.361–0.902 0.016 62 0.576 0.366–0.906 0.017
   MHC-II
    Near (≤18.68 px) 13 1.000
    Far (>18.68 px) 97 0.374 0.200–0.699 0.002
   KIR-3D
    Near (≤20.28 px) 35 1.000 35 1.000
    Far (>20.28 px) 73 2.337 1.366–3.977 0.002 73 2.444 1.379–4.330 0.002
Distance between all TCs and all TILs (one TC to one TIL)
   Near (≤44.41 px) 83 1.000
   Far (>44.41 px) 38 1.672 1.069–2.614 0.024
Distance between all TCs and positive TILs (one TC to one positive TIL)
   OX40L
    Near (≤173.56 px) 96 1.000
    Far (>173.56 px) 20 1.731 1.025–2.922 0.040
   OX40
    Near (≤445.89 px) 104 1.000
    Far (>445.89 px) 14 1.777 0.991–3.187 0.054
   MHC-II
    Near (≤44.03 px for OS, ≤135.56 px for RFS) 49 1.000 96 1.000
    Far (>44.03 px for OS, >135.56 px for RFS) 63 1.415 0.915–2.299 0.113 16 1.761 0.984–3.150 0.057
   KIR-2D
    Near (≤223.71 px) 93 1.000
    Far (>223.71 px) 16 1.833 1.031–3.258 0.039
   KIR-3D
    Near (≤21.19 px) 35 1.000 35 1.000
    Far (>21.19 px) 74 2.235 1.208–3.901 0.005 74 2.017 1.181–3.443 0.010
Percentage of positive TILs
   OX40
    Low (≤44% for OS, ≤52% for RFS) 84 1.000 95 1.000
    High (>44% for OS, >52% for RFS) 24 1.739 1.087–2.781 0.026 23 2.015 1.201–3.383 0.008
   galectin9
    Low (≤23% for OS, ≤20% for RFS) 22 1.000 20 1.000
    High (>23% for OS, >20% for RFS) 83 1.964 1.002–3.850 0.049 85 2.053 1.016–4.149 0.045
   KIR-2D
    Low (≤37%) 46 1.000
    High (>37%) 83 0.593 0.373–0.944 0.028
   KIR-3D
    Low (≤99% for OS, ≤85% for RFS) 84 1.000 26 1.000
    High (>99% for OS, >85% for RFS) 25 0.327 0.128–0.836 0.020 83 0.327 0.128–0.833 0.019
Percentage of positive TCs
   MHC-II
    Low (≤93%) 99 1.000
    High (>93%) 13 0.425 0.185–0.979 0.044
   galectin9
    Low (≤41%) 85 1.000
    High (>41%) 20 0.450 0.223–0.909 0.026
   KIR-3D
    Low (≤99%) 95 1.000
    High (>99%) 14 0.561 0.325–0.968 0.038
Clinical factors
   Surgery type
    Wedge 2 1.000
    Segmentectomy 3 9534.267 0–3.547E+56
    Lobectomy 62 7210.961 0–2.663E+56
    Bilobectomy 7 6049.498 0–2.242E+56
    Pneumonectomy 41 14177.646 0–5.236E+56
    Sleeve lobectomy 6 10961.091 0–4.059E+56 0.020
   Pathology
    Adenocarcinoma 38 1.000
    Non-adenocarcinoma 85 1.678 1.004–2.806 0.048
   T-stage
    1 85 1.000 85 1.000
    2 36 2.011 1.260–3.210 0.003 36 2.011 1.260–3.210 0.003
   N-stage
    0 63 1.000 63 1.000
    1 58 2.479 1.586–3.873 <0.0001 58 2.479 1.586–3.873 <0.0001
   M-stage
    0 114 1.000 114 1.000
    1 7 4.019 1.803–8.961 0.001 7 3.855 1.734–8.574 0.001
   Stage
    1A 80 1.000 80 1.000
    1B 41 5.188 3.242–8.301 <0.0001 41 4.092 2.574–6.504 <0.0001

No, number of each class; HR, hazard ratio; OS, overall survival; RFS, relapse-free survival; TC, tumor cell; TIL, tumor-infiltrating lymphocyte; KIR2D, killer cell immunoglobulin-like receptor-2D; KIR-3D, killer cell immunoglobulin-like receptor-3D; TIM-3, T cell immunoglobulin-3; LAG-3, lymphocyte activation gene-3; PD-1, programmed cell death receptor-1; PD-L1, programmed cell death ligand-1; MHC-II, major histocompatibility complex class II; OX40L, OX40-ligand. All cut-off points were determined by the X-Tile software.